Skip to content
10-Q

Quarterly Report

UNIGENE LABORATORIES INC

0001437749-13-005979

← back to feed
Filed
May 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Apr 30, 2013 95.98M sh
Shares Diluted Q1 2013 · Mar 31, 2013 508M sh
Shares Diluted Q1 2013 · Mar 31, 2012 95.31M sh
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$3.41M
Long Term Debt Q1 2013 · Mar 31, 2013 $58.28M
Long Term Debt Q1 2013 · Dec 31, 2012 $56.43M
Short Term Debt Q1 2013 · Mar 31, 2013 $79.51M
Cash And Equivalents Q1 2013 · Mar 31, 2013 $353.22K
Cash And Equivalents Q1 2013 · Dec 31, 2012 $3.81M
Stockholders Equity Q1 2013 · Mar 31, 2013 −$96.49M
Stockholders Equity Q1 2013 · Dec 31, 2012 −$98.74M
Current Liabilities Q1 2013 · Mar 31, 2013 $96.55M
Current Liabilities Q1 2013 · Dec 31, 2012 $104.46M
Total Liabilities Q1 2013 · Mar 31, 2013 $101.84M
Total Liabilities Q1 2013 · Dec 31, 2012 $110.05M
Current Assets Q1 2013 · Mar 31, 2013 $1.83M
Current Assets Q1 2013 · Dec 31, 2012 $5.64M
Total Assets Q1 2013 · Mar 31, 2013 $5.35M
Total Assets Q1 2013 · Dec 31, 2012 $11.31M
Eps Diluted Q1 2013 · Mar 31, 2013 −$0.01
Eps Basic Q1 2013 · Mar 31, 2013 $0.02
Eps Basic Q1 2013 · Mar 31, 2012 −$0.03
Sga Expense Q1 2013 · Mar 31, 2013 $1.98M
Rd Expense Q1 2013 · Mar 31, 2013 $850.52K
Net Income Q1 2013 · Mar 31, 2013 $1.98M
Operating Income Q1 2013 · Mar 31, 2013 −$5.36M
Cost Of Revenue Q1 2013 · Mar 31, 2013 $1.64M
Revenue Q1 2013 · Mar 31, 2013 $613.77K